Gore announces FDA approval and first commercial implant of large-diameter thoracic tapers

Gore recently announced the expansion of the Gore Tag conformable thoracic stent graft with Active Control system product line, following Food and Drug Administration (FDA) approval of four new large-diameter tapered designs: 34x28mm, 37x31mm, 40x34mm and 45x37mm. News of the…
Breaking ground: A trial to improve the care of uncomplicated type B aortic dissection

Because high-quality evidence from large, prospective multicenter trials on the best treatment of uncomplicated type B aortic dissection (uTBAD) is scarce, SVS members Firas F. Mussa, MD, a professor of vascular surgery at UT-Houston in Houston, Texas, and Panos Kougias,…
EVS 2022: Study suggests lower rates of aortic rupture, mortality after TEVAR for uncomplicated TBAD in subacute phase compared to medical management

Thoracic endovascular aortic repair (TEVAR) carried out for uncomplicated type B aortic dissections (TBAD) saw worse mortality and aortic-related outcomes when performed in the acute phase compared to those treated in the subacute phase and those managed medically. That was…
No time like the present: The moral imperative for advocacy in vascular surgery

“I’m so sorry but we have to cancel your surgery”—10 words any warm-blooded surgeon dreads uttering. This time around, it was not for the typical reasons. Our patients’ blood pressure wasn’t sky high in pre-op, and our case wasn’t being…
Greenberg Lecture raises prospect that ‘less is more and more is less’ with aortic disease treatment

Jan S. Brunkwall, MD, from the University of Cologne in Cologne, Germany, delivered the Roy Greenberg Distinguished Lecture at the 2022 Vascular Annual Meeting (VAM), telling attendees “more is less, and less is more!” when it comes to treatment for…
Study suggests more proximal landing zone is preferred for TEVAR of acute type B aortic dissections

A review evaluating the results of thoracic endovascular aortic repair (TEVAR) following acute type B aortic dissection suggests most patients have less than 2cm of proximal healthy descending thoracic aorta. In patients treated for complicated acute type B aortic dissection,…
Guidelines recognize potential role for earlier endovascular treatment of uncomplicated type B aortic dissection

New clinical practice guidelines published today aim to act as “guard rails” to determine the treatment options and best practices for managing patients with type B aortic dissection. An important update in the document is the potential for earlier endovascular…
STABLE II results published on endovascular treatment of acute complicated TBAD with Cook Zenith

Thirty-day and one-year data from the STABLE II study have been published in the April 2020 issue of the Journal of Vascular Surgery (JVS) by Joseph V. Lombardi, MD, professor and chief of vascular surgery at Cooper University Hospital, Camden, New Jersey, and…
SVS and STS release new reporting standards for type B aortic dissections

The Society for Vascular Surgery (SVS) and the Society of Thoracic Surgeons (STS) have released new reporting standards to ensure patients with type B aortic dissections (TBADs) receive appropriate treatment and care. The care of patients with type B dissections…

